Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion

Neuroscience

Volumn 94, Issue 1, 1999, Pages 39-46

  Broersen, L M ^a   Feldon, J ^b   Weiner, I ^c  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b SWISS FEDERAL INSTITUTE OF TECHNOLOGY   (Switzerland)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Latent inhibition; Locomotor activity; Medial prefrontal cortex; Prepulse inhibition; Rat; Schizophrenia

Indexed keywords

AMPHETAMINE; APOMORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; LATENT INHIBITION; LOCOMOTION; LONG TERM POTENTIATION; NONHUMAN; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SCHIZOPHRENIA; STIMULUS RESPONSE;

AMPHETAMINE; ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE AGONISTS; LOCOMOTION; MALE; NEURAL INHIBITION; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SCHIZOPHRENIA;

EID: 0032836553     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00287-0     Document Type: Article

References (90)

1. Ahlenius S., Hillegaart V., Thorell G., Magnusson O., Fowler C.J. Suppression of exploratory locomotor activity and increase in dopamine turnover following the local application of cis-flupenthixol into limbic projection areas of the rat striatum. Brain Res. 402:1987;131-138.
2. Andreasen N.C., Rezai K., Alliger R., Swayze V.W., Flaum M., Kirchner P., Cohen G., Oleary D.S. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia - assessment with xenon-133 single-photon emission computed tomography and the Tower of London. Archs gen. Psychiat. 49:1992;943-958.
3. Anscombe F. The disorder of consciousness in schizophrenia. Schizophr. Bull. 13:1987;241-260.
4. Baruch I., Hemsley D., Gray J.A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J. nerv. ment. Dis. 176:1988;598-606.
5. Bertolucci-D'Angio M., Serrano A., Driscoll P. and Scatton B. (1990) Involvement of mesocorticolimbic dopaminergic systems in emotional states. In Progress in Brain Research (eds Uylings H. B. M., Van Eden C. G., De Bruin J. P. C., Corner M. A. and Feenstra M. G. P.), Vol. 85, pp. 405-417. Elsevier, Amsterdam.
6. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Archs gen. Psychiat. 47:1990;181-188.
7. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Archs gen. Psychiat. 49:1992;206-215.
8. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
9. Broersen L.M., Heinsbroek R.P.W., de Bruin J.P.C., Laan J.B., Joosten R.N.J.M.A., Olivier B. Local pharmacological manipulations of prefrontal dopamine affect conflict behaviour in rats. Behav. Pharmac. 6:1995;395-404.
10. Broersen L.M., Heinsbroek R.P.W., de Bruin J.P.C., Olivier B. Effects of local application of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition. Biol. Psychiat. 40:1996;1083-1090.
11. Brozoski T.J., Brown R.M., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 205:1979;929-932.
12. Bubser M., Koch M. Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex. Psychopharmacology. 113:1994;487-492.
13. Bubser M., Schmidt W.J. Injection of apomorphine into the medial prefrontal cortex of the rat increases haloperidol-induced catalepsy. Biol. Psychiat. 36:1994;64-67.
14. Carter C.J., Pycock C.J. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat. Brain Res. 192:1980;163-176.
15. Deutch A.Y. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J. neural Transm., Suppl. 36:1992;61-89.
16. Deutch A.Y., Cameron D.S. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience. 46:1992;49-56.
17. Deutch A.Y., Clark W.A., Roth R.H. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res. 521:1990;311-315.
18. Deutch A. Y. and Roth R. H. (1990) The determinants of stress-induced activation of the prefrontal cortical dopamine system. In Progress in Brain Research (eds Uylings H. B. M., Van Eden C. G., De Bruin J. P. C., Corner M. A. and Feenstra M. G. P.), Vol. 85, pp. 367-403. Elsevier, Amsterdam.
19. Duvauchelle C.L., Levitin M., MacConell L.A., Lee L.K., Ettenberg A. Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward. Brain Res. 576:1992;104-110.
20. Ellenbroek B.A., Budde S., Cools A.R. Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience. 75:1996;535-542.
21. Feenstra M.G.P., Botterblom M.H.A., van Uum J.F.M. Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo: inhibition by diazepam. Neurosci. Lett. 189:1995;81-84.
22. Feldon J., Weiner I. The latent inhibition model of schizophrenic attention disorder: haloperidol and sulpiride enhance rat's ability to ignore irrelevant stimuli. Biol. Psychiat. 29:1991;635-646.
23. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 41:1991;1-24.
24. Gray J.A., Moran P.M., Grigoryan G., Peters S.L., Young A.M.J., Joseph M.H. Latent inhibition: the nucleus accumbens connection revisited. Behav. Brain Res. 88:1997;27-34.
25. Gray N.S., Hemsley D.R., Gray J.A. Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurol. Psychiat. Brain Res. 1:1992;83-89.
26. 2 binding using SPET. Schizophr. Res. 17:1995;95-107.
27. Groenewegen H. J., Wright, C. I. and Beijer A. V. J. (1996) The nucleus accumbens: gateway for limbic structures to reach the motor system? In Progress in Brain Research (eds Holstege G., Bandler R. and Saper C. B.), Vol. 107, pp. 485-521. Elsevier, Amsterdam.
28. Hoffman H.S., Ison J.R. Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol. Rev. 87:1980;175-189.
29. Humby T., Wilkinson L.S., Robbins T.W., Geyer M.A. Prepulses inhibit startle-induced reductions of extracellular dopamine in the nucleus accumbens of rat. J. Neurosci. 16:1996;2149-2156.
30. Inoue T., Tsuchiya K., Koyama T. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmac. Biochem. Behav. 49:1994;911-920.
31. Jaskiw G.E., Karoum F., Freed W.J., Phillips I., Kleinman J.E., Weinberger D.R. Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat. Brain Res. 534:1990;263-272.
32. Jaskiw G.E., Weinberger D.R., Crawley J.N. Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus. Biol. Psychiat. 29:1991;703-706.
33. Joel D., Weiner I., Feldon J. Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance of an analog of the Wisconsin Card Sorting Test, but do not disrupt latent inhibition: implications for animal models of schizophrenia. Behav. Brain Res. 85:1997;187-201.
34. Joyce E.M., Stinus L., Iversen S.D. Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug induced activity. Neuropharmacology. 22:1983;1141-1145.
35. Killcross A.S., Robbins T.W. Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology. 110:1993;479-489.
36. King D., Zigmond M.J., Finlay J.M. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience. 77:1997;141-153.
37. Koch M., Bubser M. Deficient sensorimotor gating after 6-hydroxydopamine lesion of the rat medial prefrontal cortex is reversed by haloperidol. Eur. J. Neurosci. 6:1994;1837-1845.
38. Kodsi M.H., Swerdlow N.R. Reduced prepulse inhibition after electrolytic lesions of nucleus accumbens subregions in the rat. Brain Res. 773:1997;45-52.
39. Kolachana B.S., Saunders R.C., Weinberger D.R. Augmentation of prefrontal cortical monoaminergic activity inhibits dopamine release in the caudate nucleus: an in vivo neurochemical assessment in the rhesus monkey. Neuroscience. 69:1995;859-868.
40. Kuczenski R., Segal D. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci. 9:1989;2051-2065.
41. Lacroix L., Broersen L.M., Weiner I., Feldon J. The effect of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience. 82:1998;431-442.
42. Louilot A., Le Moal M., Simon H. Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens: an in vivo voltammetric study. Neuroscience. 29:1989;45-56.
43. Lubow R.E. Latent inhibition. Psychol. Bull. 79:1973;398-407.
44. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 94:1988;507-514.
45. Mayerhoff D.I., Loebel A.D., Alvir J.M.J., Szymanski S.R., Geisler S.H., Borenstein M., Lieberman J.A. The deficit state in first-episode schizophrenia. Am. J. Psychiat. 151:1994;1417-1422.
46. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. Br. J. med. Psychol. 34:1961;103-116.
47. Mitchell J.B., Gratton A. Partial dopamine depletion of the prefrontal cortex leads to enhanced mesolimbic dopamine release elicited by repeated exposure to naturally reinforcing stimuli. J. Neurosci. 12:1992;3609-3618.
48. Morency M.A., Stewart R.J., Beninger R.J. Effects of unilateral microinjections of sulpiride into the medial prefrontal cortex on circling behavior of rats. Prog. Neuropsychopharmac. biol. Psychiat. 9:1985;735-738.
49. Morency M.A., Stewart R.J., Beninger R.J. Circling behavior following unilateral microinjections of cocaine into the medial prefrontal cortex: dopaminergic or local anesthetic effect? J. Neurosci. 7:1987;812-818.
50. Murphy B.L., Arnsten A.F.T., Goldman-Rakic P.S., Roth R.H. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. natn. Acad. Sci. U.S.A. 93:1996;1325-1329.
51. Myers R. D. (1974) Handbook of Drug and Chemical Stimulation of the Brain. Van Nostrand Reinhold, New York.
52. Nuechterlein K.H., Dawson M.E. Information processing and attentional functioning in the developmental course of the schizophrenic disorder. Schizophr. Bull. 10:1984;160-203.
53. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic, Sydney.
54. 2 dopamine receptor agonist disrupts sensorimotor gating in rats: implications for dopaminergic abnormalities in schizophrenia. Neuropsychopharmacology. 3:1990;211-218.
55. Pycock C.J., Carter C.J., Kerwin R.W. Effects of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J. Neurochem. 34:1980;91-99.
56. Radcliffe R.A., Erwin V.G. Alterations in locomotor activity after microinjections of GBR-12909, selective dopamine antagonists or neurotensin into the medial prefrontal cortex. J. Pharmac. exp. Ther. 277:1996;1467-1476.
57. Robbins T.W. The case for frontostriatal dysfunction in schizophrenia. Schizophr. Bull. 16:1990;391-402.
58. Rosin D.L., Clark W.A., Goldstein M., Roth R.H., Deutch A.Y. Effects of 6-OHDA lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience. 48:1992;831-839.
59. Routtenberg A. Intracranial chemical injection and behavior: a critical review. Behav. Biol. 7:1972;601-641.
60. Sahakian B.J., Sarna G.S., Kantamaneni B.D., Jackson A., Hutson P.H., Curzon G. Association between learning and cortical catecholamines in non-drug-treated rats. Psychopharmacology. 86:1985;339-343.
61. Simon H., Scatton B., LeMoal M. Dopaminergic A10 neurons are involved in cognitive functions. Nature. 286:1980;150-151.
62. Solomon P.R., Staton D.M. Differential effects of microinjections of D-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biol. Psychiat. 17:1982;743-756.
63. Stewart R.J., Morency M.A., Beninger R.J. Differential effects of intrafrontocortical microinjections of dopamine agonists and antagonists on circling behavior of rats. Behav. Brain Res. 17:1985;67-72.
64. Swanson L. W. (1992) Brain Maps: Structure of the Rat Brain. Elsevier, Amsterdam.
65. Swerdlow N.R., Braff D.L., Geyer M.A., Koob G.F. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol. Psychiat. 21:1986;23-33.
66. Swerdlow N.R., Braff D.L., Hartston H., Perry W., Geyer M.A. Latent inhibition in schizophrenia. Schizophr. Res. 20:1996;91-103.
67. Swerdlow N.R., Braff D.L., Masten V.L., Geyer M.A. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology. 101:1990;414-420.
68. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Archs gen. Psychiat. 51:1994;139-154.
69. Swerdlow N.R., Caine S.B., Geyer M.A. Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology. 108:1992;189-195.
70. Swerdlow N.R., Lipska B.K., Weinberger D.R., Braff D.L., Jaskiw G.E., Geyer M.A. Increased sensitivity to the sensorimotor gating-disruptive effect of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rat. Psychopharmacology. 122:1995;27-34.
71. Swerdlow N.R., Mansbach R.S., Geyer M.A., Pulvirenti L., Koob G., Braff D.L. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine Psychopharmacology. 100:1990;413-416.
72. Taber M.T., Fibiger H.C. Electrical stimulation of the medial prefrontal cortex increases dopamine release in the striatum. Neuropsychopharmacology. 9:1993;271-275.
73. Taber M.T., Fibiger H.C. Activation of the mesocortical dopamine system by feeding: lack of a selective response to stress. Neuroscience. 77:1997;295-298.
74. Tai C.T., Cassaday H.J., Feldon J., Rawlins J.N.P. Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition of learning in rats. Neurobiol. Learn. Mem. 64:1995;36-48.
75. Thompson T.L., Moss R.L. In vivo stimulated dopamine release in the nucleus accumbens: modulation by the prefrontal cortex. Brain Res. 686:1995;93-98.
76. Vaitl D., Lipp O.V. Latent inhibition and autonomic responses: a psychophysiological approach. Behav. Brain Res. 88:1997;85-93.
77. van Eden C.G., Lamme V.A.F., Uylings H.B.M. Heterotopic cortical afferents to the medial prefrontal cortex in the rat. A combined retrograde and anterograde tracer study. Eur. J. Neurosci. 4:1992;77-97.
78. Vezina P., Blanc G., Glowinski J., Tassin J.P. Opposed behavioural outputs of increased dopamine transmission in prefrontocortical and subcortical areas: a role for the cortical D-1 dopamine receptor. Eur. J. Neurosci. 3:1991;1001-1007.
79. 2 modulation of sensorimotor gating in rats: assessing anatomical localization. Pharmac. Biochem. Behav. 49:1994;155-163.
80. Wan F.J., Geyer M.A., Swerdlow N.R. Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating. Psychopharmacology. 120:1995;433-442.
81. Wan F.J., Swerdlow N.R. Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology. 113:1993;103-109.
82. Wan F.J., Swerdlow N.R. Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Res. 722:1996;168-176.
83. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Archs gen. Psychiat. 44:1987;660-669.
84. Weiner I., Feldon J. Facilitation of latent inhibition by haloperidol. Psychopharmacology. 91:1987;248-253.
85. Weiner I., Gal G., Rawlins J.N.P., Feldon J. Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and in amphetamine induced activity. Behav. Brain Res. 81:1996;123-133.
86. Wilkinson L.S., Humby T., Killcross A.S., Torres E.M., Everitt B.J., Robbins T.W. Dissociations in dopamine release in medial prefrontal cortex and ventral striatum during the acquisition and extinction of classical aversive conditioning in the rat. Eur. J. Neurosci. 10:1998;1019-1026.
87. Wilkinson L.S., Killcross S.S., Humby T., Hall F.S., Geyer M.A., Robbins T.W. Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition. Neuropsychopharmacology. 10:1994;61-72.
88. 1 receptors in prefrontal cortex. Nature. 376:1995;572-575.
89. Wolkin A., Sanfilipo M., Wolf A.P., Angrist B., Brodie J.D., Rotrosen J. Negative symptoms and hypofrontality in chronic schizophrenia. Archs gen. Psychiat. 49:1992;959-965.
90. Young A.M.J., Joseph M.H., Gray J.A. Latent inhibition of conditioned dopamine release in rat nucleus accumbens. Neuroscience. 54:1993;5-9.